<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPR</journal-id>
<journal-id journal-id-type="hwp">spcpr</journal-id>
<journal-title>European Journal of Preventive Cardiology</journal-title>
<issn pub-type="ppub">2047-4873</issn>
<issn pub-type="epub">2047-4881</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1741826711414626</article-id>
<article-id pub-id-type="publisher-id">10.1177_1741826711414626</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Rehabilitation</subject>
<subj-group subj-group-type="heading">
<subject>Original scientific papers</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Antunes-Correa</surname><given-names>Ligia M</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kanamura</surname><given-names>Bianca Y</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Melo</surname><given-names>Ruth C</given-names></name>
<xref ref-type="aff" rid="aff2-1741826711414626">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nobre</surname><given-names>Thais S</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ueno</surname><given-names>Linda M</given-names></name>
<xref ref-type="aff" rid="aff2-1741826711414626">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Franco</surname><given-names>Fabio GM</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Roveda</surname><given-names>Fabiana</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Braga</surname><given-names>Ana Maria</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rondon</surname><given-names>Maria UPB</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
<xref ref-type="aff" rid="aff3-1741826711414626">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Brum</surname><given-names>Patricia C</given-names></name>
<xref ref-type="aff" rid="aff3-1741826711414626">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Barretto</surname><given-names>Antonio CP</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Middlekauff</surname><given-names>Holly R</given-names></name>
<xref ref-type="aff" rid="aff4-1741826711414626">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Negrao</surname><given-names>Carlos E</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711414626">1</xref>
<xref ref-type="aff" rid="aff3-1741826711414626">3</xref>
<xref ref-type="corresp" rid="corresp1-1741826711414626"/>
</contrib>
</contrib-group>
<aff id="aff1-1741826711414626"><label>1</label>Heart Institute (InCor), University of Sao Paulo Medical School, Sao Paulo, Brazil.</aff>
<aff id="aff2-1741826711414626"><label>2</label>School of Arts, Sciences and Humanities, University of Sao Paulo, Sao Paulo, Brazil.</aff>
<aff id="aff3-1741826711414626"><label>3</label>School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, Brazil.</aff>
<aff id="aff4-1741826711414626"><label>4</label>Departament of Medicine (Cardiology) and Physiology, Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.</aff>
<author-notes>
<corresp id="corresp1-1741826711414626">Carlos Eduardo Negrao, Heart Institute (InCor)<bold>,</bold> Av. Dr. Eneas de Carvalho Aguiar, 44–Cerqueira Cesar–Sao Paulo–SP<bold>,</bold> CEP 05403-904- Brazil Email: <email>cndnegrao@incor.usp.br</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>4</issue>
<fpage>822</fpage>
<lpage>829</lpage>
<history>
<date date-type="received"><day>14</day><month>2</month><year>2011</year></date>
<date date-type="accepted"><day>2</day><month>6</month><year>2011</year></date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<p><bold>Background:</bold> Exercise training is a non-pharmacological strategy for treatment of heart failure. Exercise training improves functional capacity and quality of life in patients. Moreover, exercise training reduces muscle sympathetic nerve activity (MSNA) and peripheral vasoconstriction. However, most of these studies have been conducted in middle-aged patients. Thus, the effects of exercise training in older patients are much less understood. The present study was undertaken to investigate whether exercise training improves functional capacity, muscular sympathetic activation and muscular blood flow in older heart failure patients, as it does in middle-aged heart failure patients.</p>
<p><bold>Design:</bold> Fifty-two consecutive outpatients with heart failure from the database of the Unit of Cardiovascular Rehabilitation and Physiology Exercise were divided by age (middle-aged, defined as 45–59 years, and older, defined as 60–75 years) and exercise status (trained and untrained).</p>
<p><bold>Methods:</bold> MSNA was recorded directly from the peroneal nerve using the microneurography technique. Forearm Blood Flow (FBF) was measured by venous occlusion plethysmography. Functional capacity was evaluated by cardiopulmonary exercise test.</p>
<p><bold>Results:</bold> Exercise training significantly and similarly increased FBF and peak VO<sub>2</sub> in middle-aged and older heart failure patients. In addition, exercise training significantly and similarly reduced MSNA and forearm vascular resistance in these patients. No significant changes were found in untrained patients.</p>
<p><bold>Conclusion:</bold> Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age.</p>
</abstract>
<kwd-group>
<kwd>Heart failure</kwd>
<kwd>age</kwd>
<kwd>exercise training</kwd>
<kwd>forearm blood flow</kwd>
<kwd>muscle sympathetic nerve activity</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1741826711414626" sec-type="intro"><title>Introduction</title>
<p>Heart failure is a complex syndrome associated with exercise intolerance and poor prognosis.<sup><xref ref-type="bibr" rid="bibr1-1741826711414626">1</xref>,<xref ref-type="bibr" rid="bibr2-1741826711414626">2</xref></sup> Both the incidence and prevalence of heart failure have increased in recent years.<sup><xref ref-type="bibr" rid="bibr3-1741826711414626">3</xref></sup> In addition, the incidence will increase even further due to the aging of the population and the increasing survival rates of patients with cardiac disease.<sup><xref ref-type="bibr" rid="bibr3-1741826711414626">3</xref></sup> Aging is associated with increased left ventricular mass, myocardial stiffness, atrial fibrillation and decreased maximum oxygen uptake.<sup><xref ref-type="bibr" rid="bibr4-1741826711414626">4</xref></sup> In addition, aging predisposes to diabetes, obesity and hypertension.<sup><xref ref-type="bibr" rid="bibr5-1741826711414626">5</xref></sup> All these alterations increase the susceptibility for developing of heart failure.<sup><xref ref-type="bibr" rid="bibr3-1741826711414626">3</xref>,<xref ref-type="bibr" rid="bibr4-1741826711414626">4</xref></sup> Statistics show that the incidence of this syndrome increases progressively each subsequent decade and affects as many as 10–15% of people over the age of 65 years.<sup><xref ref-type="bibr" rid="bibr3-1741826711414626">3</xref></sup> In fact, heart failure has been a major cause of hospitalization in the elderly over the last 25 years.<sup><xref ref-type="bibr" rid="bibr6-1741826711414626">6</xref></sup></p>
<p>Chronic heart failure patients have abnormalities of skeletal muscle, including decreased mass and oxidative capacity. Several lines of evidence suggest that cardiac dysfunction increases sympathetic nerve activity and renin-angiotensin system activity, contributing to chronic vasoconstriction and muscle blood flow reduction that, in turn, leads to oxidative stress and inflammation.<sup><xref ref-type="bibr" rid="bibr7-1741826711414626">7</xref>,<xref ref-type="bibr" rid="bibr8-1741826711414626">8</xref></sup> As the aging process is also accompanied by an increase in sympathetic activity and a reduction in vascular function,<sup><xref ref-type="bibr" rid="bibr9-1741826711414626">9</xref>,<xref ref-type="bibr" rid="bibr10-1741826711414626">10</xref></sup> its association with cardiac dysfunction may have an additive effect on worsening of neurovascular control.</p>
<p>Exercise training is a non-pharmacological strategy for the treatment of heart failure patients. Exercise training has been shown to improve functional capacity and quality of life in these patients.<sup><xref ref-type="bibr" rid="bibr11-1741826711414626">11</xref>,<xref ref-type="bibr" rid="bibr12-1741826711414626">12</xref></sup> Moreover, exercise training reduces sympathetic nerve activity and peripheral vasoconstriction.<sup><xref ref-type="bibr" rid="bibr11-1741826711414626">11</xref>,<xref ref-type="bibr" rid="bibr13-1741826711414626">13</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-1741826711414626">15</xref></sup> However, most of these studies have been conducted in middle-aged patients (&lt;65 years). Thus, the effects of exercise training in older patients are much less understood.</p>
<p>The present study was undertaken to investigate whether the effects of exercise training on functional capacity, muscular sympathetic activation and muscular blood flow would be similar between middle-aged patients (45–59 years) and older patients (60–75 years) with chronic heart failure.</p>
</sec>
<sec id="sec2-1741826711414626" sec-type="methods"><title>Methods</title>
<sec id="sec3-1741826711414626"><title>Study population</title>
<p>Patients with clinical stable heart failure, aged between 45 and 75 years, New York Heart Association functional (NYHA) Class II to III and ejection fraction ≤40% were included in the study. Patients with unstable angina, recent myocardial infarction (less than 3 months), severe chronic obstructive pulmonary disease, uncontrolled systemic arterial hypertension and/or neurological or orthopedic disabilities were excluded.</p>
</sec>
<sec id="sec4-1741826711414626"><title>Study protocol</title>
<p>Fifty-two consecutive outpatients with heart failure from data base of previous randomized studies<sup><xref ref-type="bibr" rid="bibr11-1741826711414626">11</xref>,<xref ref-type="bibr" rid="bibr13-1741826711414626">13</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-1741826711414626">15</xref></sup> of the Unit of Cardiovascular Rehabilitation and Exercise Physiology, Heart Institute, University of Sao Paulo Medical School. The patients were divided into two groups according to age: (1) middle-aged heart failure patients (45–59 years) and (2) older heart failure patients (60–75 years). Each group was further divided into an exercise-training group and a clinical follow-up group (middle-aged exercise-trained, <italic>n </italic>= 16; middle-aged untrained, <italic>n </italic>= 17; older exercise-trained, <italic>n </italic>= 11 and older untrained, <italic>n </italic>= 8). The study was approved by The Human Subject Protection Committee of the Heart Institute and Clinical Hospital, University of Sao Paulo Medical School.</p>
</sec>
<sec id="sec5-1741826711414626"><title>Exercise training programme</title>
<p>The training programme was based on several published protocols that have demonstrated a conditioning effect.<sup><xref ref-type="bibr" rid="bibr16-1741826711414626">16</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr19-1741826711414626">19</xref></sup> The four-month training programme consisted of three 60 min exercise sessions/week. Each exercise session consisted of 5 min stretching exercises, 25 min on the cycle ergometer in the first month and up to 40 min in the last three months, 10 min of strengthening exercises and 5 min of cool down. The exercise intensity was established by heart rate levels that corresponded to anaerobic thresholds up to 10% below the respiratory compensation point obtained in the cardiopulmonary exercise test. When a training effect was observed, as indicated by the patients using a Borg Perceived Exertion Scale, the bicycle work rate was increased by 0.25 kpm or 0.5 kpm to return to the target heart rate levels. Aerobic exercise training duration increased progressively so that all patients could perform 40 min of bicycle exercise at the established intensity. The control patients were instructed to avoid any regular exercise programme or any non-supervised exercise programme during the study.</p>
</sec>
<sec id="sec6-1741826711414626"><title>Forearm blood flow measurements</title>
<p>Forearm blood flow (FBF) was measured by venous occlusion plethysmography as previously described.<sup><xref ref-type="bibr" rid="bibr20-1741826711414626">20</xref></sup> Forearm vascular resistance (FVR) was calculated by dividing mean arterial pressure by FBF.</p>
</sec>
<sec id="sec7-1741826711414626"><title>Muscle sympathetic nerve activity measurements</title>
<p>Muscle sympathetic nerve activity (MSNA) was recorded directly from the peroneal nerve using the technique of microneurography, as previously described.<sup><xref ref-type="bibr" rid="bibr21-1741826711414626">21</xref>,<xref ref-type="bibr" rid="bibr22-1741826711414626">22</xref></sup></p>
</sec>
<sec id="sec8-1741826711414626"><title>Functional capacity measurements</title>
<p>Maximal exercise capacity was determined by means of a maximal progressive exercise test on a cycle ergometer (Medifit 400 L, Medical Fitness Equipment, Maarn, Netherlands), using a ramp protocol (5–10 W), as previously reported.<sup><xref ref-type="bibr" rid="bibr13-1741826711414626">13</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-1741826711414626">15</xref>,<xref ref-type="bibr" rid="bibr23-1741826711414626">23</xref></sup></p>
</sec>
<sec id="sec9-1741826711414626"><title>Blood pressure, heart rate measurements and ejection fraction</title>
<p>Blood pressure was monitored non-invasively using oscillometric cuffs (Dixtal, DX 2710, Brazil, Manaus). Heart rate was monitored continuously through an electrocardiogram. Ejection fraction was determined from the two-dimensional echocardiography by Simpson's method.<sup><xref ref-type="bibr" rid="bibr24-1741826711414626">24</xref></sup></p>
</sec>
<sec id="sec10-1741826711414626"><title>Statistical analysis</title>
<p>The data are presented as mean ± SE or number of participants and (percentage) or (95% confidence interval). Possible baseline differences among the four groups were evaluated by one-way analysis of variance. The effect of exercise training in middle-aged heart failure patients and older heart failure patients was evaluated by unpaired T-test. The interaction of exercise training and age was analysed by two-way analysis of variance. Scheffé’s post hoc comparison was used to determine the differences between groups. In addition, the multivariable logistic regression was used to determine whether age was associated with exercise training changes. A <italic>p </italic>&lt; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="sec11-1741826711414626" sec-type="results"><title>Results</title>
<sec id="sec12-1741826711414626"><title>Baseline characteristics</title>
<p>Baseline characteristics are displayed in <xref ref-type="table" rid="table1-1741826711414626">Table 1</xref>. There were no significant differences among groups in body mass index, left ventricular ejection fraction, peak oxygen uptake, heart rate, mean arterial pressure, MSNA, FBF and FVR.
<table-wrap id="table1-1741826711414626" position="float"><label>Table 1.</label><caption><p>Baseline physiology parameters</p></caption>
<graphic alternate-form-of="table1-1741826711414626" xlink:href="10.1177_1741826711414626-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th>Middle-aged untrained (<italic>n </italic>= 17)</th>
<th>Middle-aged exercise trained (<italic>n </italic>= 16)</th>
<th>Older untrained (<italic>n </italic>= 8)</th>
<th>Older exercise trained (n<italic> </italic>= 11)</th></tr></thead>
<tbody align="left">
<tr>
<td>Age (years)</td>
<td>50 ± 1.5</td>
<td>52 ± 1.5</td>
<td>64 ± 1.0<sup><xref ref-type="table-fn" rid="table-fn2-1741826711414626">a</xref></sup></td>
<td>66 ± 1.4<sup><xref ref-type="table-fn" rid="table-fn2-1741826711414626">a</xref></sup></td></tr>
<tr>
<td colspan="5">Gender</td></tr>
<tr>
<td> Male</td>
<td>8 (47%)</td>
<td>8 (50%)</td>
<td>4 (50%)</td>
<td>7 (64%)</td></tr>
<tr>
<td> Female</td>
<td>9 (53%)</td>
<td>8 (50%)</td>
<td>4 (50%)</td>
<td>4 (36%)</td></tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>24 ± 0.9</td>
<td>25 ± 0.8</td>
<td>25 ± 1.4</td>
<td>25 ± 1.0</td></tr>
<tr>
<td colspan="5">Functional Class (NYHA)</td></tr>
<tr>
<td> II</td>
<td>12 (71%)</td>
<td>7 (44%)</td>
<td>4 (50%)</td>
<td>6 (54%)</td></tr>
<tr>
<td> III</td>
<td>5 (29%)</td>
<td>9 (56%)</td>
<td>4 (50%)</td>
<td>5 (46%)</td></tr>
<tr>
<td colspan="5">HF aetiology</td></tr>
<tr>
<td> Idiopathic</td>
<td>8 (47%)</td>
<td>6 (37.5%)</td>
<td>4 (50%)</td>
<td>5 (46%)</td></tr>
<tr>
<td> Chagas</td>
<td>4 (23.5%)</td>
<td>4 (25%)</td>
<td>0</td>
<td>0</td></tr>
<tr>
<td> Ischaemic</td>
<td>1 (6%)</td>
<td>2 (12.5%)</td>
<td>0</td>
<td>4 (36%)</td></tr>
<tr>
<td> Hypertensive</td>
<td>4 (23.5%)</td>
<td>4 (25%)</td>
<td>4 (50%)</td>
<td>2 (18%)</td></tr>
<tr>
<td colspan="5">Medications</td></tr>
<tr>
<td> ACEI /ARB</td>
<td>17 (100%)</td>
<td>16 (100%)</td>
<td>8 (100%)</td>
<td>11 (100%)</td></tr>
<tr>
<td> Digoxin</td>
<td>14 (82%)</td>
<td>14 (87%)</td>
<td>6 (75%)</td>
<td>7 (64%)</td></tr>
<tr>
<td> Diuretics</td>
<td>16 (94%)</td>
<td>16 (100%)</td>
<td>8 (100%)</td>
<td>8 (73%)</td></tr>
<tr>
<td> Spiroloctone</td>
<td>11 (65%)</td>
<td>10 (62%)</td>
<td>4 (50%)</td>
<td>6 (54%)</td></tr>
<tr>
<td>Beta-adrenergic blocker</td>
<td>9 (53%)</td>
<td>11 (67%)</td>
<td>7 (87%)</td>
<td>8 (73%)</td></tr>
<tr>
<td>LVEF (%)</td>
<td>29 ± 2.1</td>
<td>29 ± 1.5</td>
<td>30 ± 2.3</td>
<td>29 ± 2.3</td></tr>
<tr>
<td>Peak VO<sub>2</sub> (ml/kg/min)</td>
<td>17 ± 0.8</td>
<td>14 ± 1.0</td>
<td>15 ± 1.1</td>
<td>15 ± 1.3</td></tr>
<tr>
<td>Heart rate (beats/min)</td>
<td>73 ± 3.5</td>
<td>72 ± 2.5</td>
<td>65 ± 3.7</td>
<td>66 ± 3.4</td></tr>
<tr>
<td>MAP (mmHg)</td>
<td>96 ± 3.5</td>
<td>94 ± 4.2</td>
<td>95 ± 4.9</td>
<td>87 ± 3.9</td></tr>
<tr>
<td>MSNA (burst/min)</td>
<td>43 ± 2.4</td>
<td>46 ± 3.2</td>
<td>50 ± 3.8</td>
<td>45 ± 4.0</td></tr>
<tr>
<td>MSNA (burst/100 heart beats)</td>
<td>66 ± 3.6</td>
<td>70 ± 4.6</td>
<td>83 ± 6.5</td>
<td>72 ± 5.9</td></tr>
<tr>
<td>FBF (ml/min/100 ml tissue)</td>
<td>1.96 ± 0.1</td>
<td>1.69 ± 0.1</td>
<td>1.64 ± 0.2</td>
<td>1.47 ± 0.1</td></tr>
<tr>
<td>FVR (U)</td>
<td>52 ± 4.1</td>
<td>57 ± 3.6</td>
<td>63 ± 6.4</td>
<td>57 ± 3.3</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1741826711414626"><p>Values are mean  ±  SE. Significant difference vs. middle age, <sup>a</sup><italic>p </italic>&lt; 0.001.</p></fn>
<fn id="table-fn2-1741826711414626"><p>BMI, body mass index; NYHA, New York Heart Association; HF, heart failure; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blocker; LVEF, left ventricular ejection fraction; VO<sub>2,</sub> oxygen uptake; MAP, mean arterial pressure; MSNA, muscle sympathetic nerve activity; FBF, forearm blood flow; FVR, forearm vascular resistance.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec13-1741826711414626"><title>Impact of exercise training</title>
<p>The effects of exercise training in middle-aged and older heart failure patients are shown in <xref ref-type="table" rid="table2-1741826711414626">Table 2</xref>. Exercise training caused no changes in ejection fraction and peak VO<sub>2,</sub> heart rate in middle-aged and older patients. However, exercise training significantly reduced MSNA and FVR and significantly increased FBF in both groups.
<table-wrap id="table2-1741826711414626" position="float"><label>Table 2.</label><caption><p>Effect of exercise training in middle-aged and older heart failure patients</p></caption>
<graphic alternate-form-of="table2-1741826711414626" xlink:href="10.1177_1741826711414626-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th>Middle-aged untrained (<italic>n </italic>= 17)</th>
<th>Middle-aged exercise trained (<italic>n </italic>= 16)</th>
<th>Older untrained (<italic>n </italic>= 8)</th>
<th>Older Exercise-Trained (n<italic> </italic>= 11)</th></tr></thead>
<tbody align="left">
<tr>
<td>LVEF (%)</td>
<td>32 (28.9–35.6)</td>
<td>31 (27.7–33.9)</td>
<td>29 (23.6–33.4)</td>
<td>32 (27.3–36.3)</td></tr>
<tr>
<td>Peak VO<sub>2</sub> (ml/kg/min)</td>
<td>17 (15.6–19.3)</td>
<td>17 (14.2–20.7)</td>
<td>14 (12.3–16.6)</td>
<td>18 (15.4–21.1)</td></tr>
<tr>
<td>Heart rate (beats/min)</td>
<td>72 (66.6–77.1)</td>
<td>69 (64.3–74.4)</td>
<td>65 (55.0–74.0)</td>
<td>61 (54.5–67.6)</td></tr>
<tr>
<td>MAP (mmHg)</td>
<td>95 (90.0–100.7)</td>
<td>90 (83.6–97.3)</td>
<td>98 (87.9–108.7)</td>
<td>85 (77.0–92.4)<sup><xref ref-type="table-fn" rid="table-fn5-1741826711414626">a</xref></sup></td></tr>
<tr>
<td>MSNA (burst/min)</td>
<td>46 (42.3–50.1)</td>
<td>27 (23.7–46.0)<sup><xref ref-type="table-fn" rid="table-fn7-1741826711414626">c</xref></sup></td>
<td>40 (41.0–57.2)</td>
<td>29 (24.2–34.3)<sup><xref ref-type="table-fn" rid="table-fn7-1741826711414626">c</xref></sup></td></tr>
<tr>
<td>MSNA (burst/100 HB)</td>
<td>71 (65.9–76.5)</td>
<td>41 (35.5–78.9)<sup><xref ref-type="table-fn" rid="table-fn7-1741826711414626">c</xref></sup></td>
<td>81 (66.5–95.7)</td>
<td>48 (42.3–54.8)<sup><xref ref-type="table-fn" rid="table-fn7-1741826711414626">c</xref></sup></td></tr>
<tr>
<td>FBF (ml/min/100 ml tissue)</td>
<td>1.88 (1.60–2.15)</td>
<td>2.39 (1.96–2.81)<sup><xref ref-type="table-fn" rid="table-fn5-1741826711414626">a</xref></sup></td>
<td>1.54 (1.39–1.68)</td>
<td>2.18 (1.78–2.59)<sup><xref ref-type="table-fn" rid="table-fn5-1741826711414626">a</xref></sup></td></tr>
<tr>
<td>FVR (U)</td>
<td>56 (46.3–65.4)</td>
<td>39 (33.0–44.4)<sup><xref ref-type="table-fn" rid="table-fn6-1741826711414626">b</xref></sup></td>
<td>65 (61.2–68.3)</td>
<td>40.6 (35.6–45.7)<sup><xref ref-type="table-fn" rid="table-fn7-1741826711414626">c</xref></sup></td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1741826711414626"><p>Values are for mean (95% confidence interval in parentheses). Significant difference vs. untrained group:</p></fn>
<fn id="table-fn4-1741826711414626"><label>a</label><p>p<italic> </italic>&lt; 0.05,</p></fn>
<fn id="table-fn5-1741826711414626"><label>b</label><p>p<italic> </italic>&lt; 0.01 and</p></fn>
<fn id="table-fn6-1741826711414626"><label>c</label><p>p<italic> </italic>&lt; 0.001. LVEF, left ventricular ejection fraction; VO<sub>2,</sub> oxygen uptake; MAP, mean arterial pressure; MSNA, muscle sympathetic nerve activity; FBF, forearm blood flow; FVR, forearm vascular resistance.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>In relation to interaction of exercise training and age, we found that exercise training significantly and similarly reduced muscle sympathetic burst frequency (<xref ref-type="fig" rid="fig1-1741826711414626">Figure 1</xref>A, exercise training effect, <italic>p </italic>&lt; 0.0001 and age effect, <italic>p </italic>= 0.69) and muscle sympathetic burst incidence (<xref ref-type="fig" rid="fig1-1741826711414626">Figure 1</xref>B, exercise training effect, <italic>p </italic>= 0.0001 and age effect, <italic>p </italic>= 0.87) in middle-aged and older patients. Exercise training significantly and similarly increased FBF (<xref ref-type="fig" rid="fig2-1741826711414626">Figure 2</xref>A, exercise training effect, <italic>p </italic>&lt; 0.0001 and age effect, <italic>p </italic>= 0.98) and significantly and similarly reduced FVR (<xref ref-type="fig" rid="fig2-1741826711414626">Figure 2</xref>B, exercise training effect, <italic>p </italic>= 0.008 and age effect, <italic>p </italic>= 0.62) in middle-aged and older patients. Exercise training significantly increased peak VO<sub>2</sub> (exercise training effect, <italic>p </italic>&lt; 0.001 and age effect, <italic>p </italic>= 0.27) in both middle-aged heart failure patients and older heart failure patients (<xref ref-type="table" rid="table3-1741826711414626">Table 3</xref>). No significant changes were found in untrained patients. Further analysis showed no significant association between age and changes in peak VO<sub>2</sub> (<italic>r </italic>= 0.2039, <italic>p </italic>= 0.58), MSNA (<italic>r </italic>= 0.0579, <italic>p </italic>= 0.25), FBF (<italic>r </italic>= 0.1122, <italic>p </italic>= 0.93) and FVR (<italic>r </italic>= 0.0430, <italic>p </italic>= 0.27) provoked by exercise training. Exercise training improved NYHA Functional Class. After four months of follow up, 14 patients (82%) were in Class II and three patients (18%) in Class III in middle-aged group, and two patients (25%) were in Class II and six patients (75%) in Class III in older group. In contrast, after four months of exercise training, six patients (37.5%) were in Class I and 10 patients (62.5%) in Class II in the middle-aged group, and six patients (54%) were in Class I and 5 patients (46%) in Class II in older group.
<fig id="fig1-1741826711414626" position="float"><label>Figure 1.</label><caption><p>Delta changes in muscle sympathetic nerve activity (MSNA) quantified as bursts/min (A) and bursts/100 heart beats (B) in untrained and exercised-trained middle-aged heart failure patients and untrained and exercised-trained older heart failure patients. Exercise training markedly and similarly reduced MSNA levels in middle-aged and older heart failure patients. MSNA levels were not significantly changed in untrained heart failure patients. Significant difference vs. untrained, ***<italic>p </italic>&lt; 0.001. ET<italic> </italic>= exercise trained; UT<italic> </italic>= untrained.</p></caption><graphic xlink:href="10.1177_1741826711414626-fig1.tif"/></fig>
<fig id="fig2-1741826711414626" position="float"><label>Figure 2.</label><caption><p>Delta changes forearm blood flow (FBF) (A) and forearm vascular resistance (FVR) (B) in untrained and exercised-trained middle-aged heart failure patients and untrained and exercised-trained older heart failure patients. Exercise training markedly and similarly increased FBF levels in middle-aged and older heart failure patients. In addition, exercise training significantly and similarly reduced FVR in middle-aged and older heart failure patients. FBF and FVR were not significantly changed in untrained heart failure patients. Significant difference vs. untrained, ***<italic>p </italic>&lt; 0.001. ET<italic> </italic>= exercise trained; UT<italic> </italic>= untrained.</p></caption><graphic xlink:href="10.1177_1741826711414626-fig2.tif"/></fig>
<table-wrap id="table3-1741826711414626" position="float"><label>Table 3.</label><caption><p>Absolute changes after exercise training or clinical follow-up in middle-aged and older heart failure patients</p></caption>
<graphic alternate-form-of="table3-1741826711414626" xlink:href="10.1177_1741826711414626-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th>Middle-aged untrained (<italic>n </italic>= 17)</th>
<th>Middle-aged exercise trained (<italic>n </italic>= 16)</th>
<th>Older untrained (<italic>n </italic>= 8)</th>
<th>Older exercise trained (<italic>n </italic>= 11)</th>
<th>Training effect (<italic>p</italic>)</th>
<th>Age effect (<italic>p</italic>)</th>
<th>Interaction (<italic>p</italic>)</th></tr></thead>
<tbody align="left">
<tr>
<td>LVEF (%)</td>
<td>2.8 (−0.3–6.0)</td>
<td>1.4 (−1.4–4.3)</td>
<td>−1.3 (−4.1–1.6)</td>
<td>3.2 (0.1–6.3)</td>
<td>NS</td>
<td>NS</td>
<td>NS</td></tr>
<tr>
<td>Peak VO<sub>2</sub> (ml/kg/min)</td>
<td>0.8 (−0.2–1.8)</td>
<td>4.0 (1.8–61)</td>
<td>−0.2 (−2.5–2.2)</td>
<td>3.5 (2.3–4.7)</td>
<td>0.001</td>
<td>NS</td>
<td>NS</td></tr>
<tr>
<td>Heart rate (beats/min)</td>
<td>−1.3 (−6.4–3.7)</td>
<td>−2.3 (−7.5–2.9)</td>
<td>−0.2 (−4.6–4.2)</td>
<td>−4.9 (−10.2–0.4)</td>
<td>NS</td>
<td>NS</td>
<td>NS</td></tr>
<tr>
<td>MAP (mmHg)</td>
<td>−0.5 (−6.6–5.6)</td>
<td>−3.1 (−10.0–3.8)</td>
<td>2.8 (−1.3–7.0)</td>
<td>−2.5 (−6.9–1.8)</td>
<td>NS</td>
<td>NS</td>
<td>NS</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-1741826711414626"><p>Values are for mean (95% confidence interval in parentheses). NS, not significant; LVEF, left ventricular ejection fraction; VO<sub>2</sub>, oxygen uptake; MAP, mean arterial pressure.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
</sec>
<sec id="sec14-1741826711414626" sec-type="discussion"><title>Discussion</title>
<p>Previous studies have shown that exercise training significantly reduces MSNA and significantly increases muscle blood flow in patients with chronic heart failure.<sup><xref ref-type="bibr" rid="bibr11-1741826711414626">11</xref>,<xref ref-type="bibr" rid="bibr13-1741826711414626">13</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-1741826711414626">15</xref></sup> The present study confirms these findings and provides the knowledge that the reduction in MSNA and vasoconstriction after exercise training is similar in middle-aged and older heart failure patients. In addition, our study demonstrates that the benefits of exercise training in functional capacity, expressed by peak VO<sub>2,</sub> occur in both middle-aged and older patients.</p>
<p>Observational studies demonstrate that healthy older individuals have augmented sympathetic nerve activity when compared with healthy middle-aged individuals.<sup><xref ref-type="bibr" rid="bibr9-1741826711414626">9</xref>,<xref ref-type="bibr" rid="bibr10-1741826711414626">10</xref></sup> Interestingly, our study shows that MSNA is no different in middle-aged and older heart failure patients, which suggests that a dominant influence on the increased MSNA in this syndrome is cardiac dysfunction. This finding is consistent with a previous study, in which increasing MSNA levels were associated with progressive left ventricular dysfunction.<sup><xref ref-type="bibr" rid="bibr25-1741826711414626">25</xref></sup></p>
<p>The mechanisms by which exercise training reduces sympathetic nerve activity in humans with heart failure remains poorly understood. However, findings in animal models provide information that the decrease in sympathetic outflow after exercise training can be, in part, due to the restoration in baroreflex control.<sup><xref ref-type="bibr" rid="bibr26-1741826711414626">26</xref></sup> Previous studies demonstrated that exercise training causes a significant increase in aortic depressor nerve sensitivity<sup><xref ref-type="bibr" rid="bibr26-1741826711414626">26</xref></sup> and a significant decrease in angiotensin II in the central nervous system that mediates the arterial baroreflex functioning.<sup><xref ref-type="bibr" rid="bibr27-1741826711414626">27</xref></sup> It is also possible that the reduction in sympathetic nerve activity is associated with an improvement in chemoreflex control due to an increase in nitric oxide synthesis in the carotid body.<sup><xref ref-type="bibr" rid="bibr28-1741826711414626">28</xref></sup></p>
<p>Aging gradually decreases muscle blood flow.<sup><xref ref-type="bibr" rid="bibr29-1741826711414626">29</xref>,<xref ref-type="bibr" rid="bibr30-1741826711414626">30</xref></sup> This haemodynamic alteration has been attributed to increased intimal thickness, arterial stiffness, MSNA and decreased endothelial function.<sup><xref ref-type="bibr" rid="bibr31-1741826711414626">31</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr33-1741826711414626">33</xref></sup> Our study clearly demonstrates that exercise training improves FBF in both middle-aged and older heart failure patients. This increase in forearm vascular conductance may be attributable to the dramatic reduction in MSNA. Additionally, exercise training has been shown to improve endothelial function and to increase blood flow in response to intra-arterial infusion of acetylcholine.<sup><xref ref-type="bibr" rid="bibr34-1741826711414626">34</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr36-1741826711414626">36</xref></sup></p>
<sec id="sec15-1741826711414626"><title>Limitations</title>
<p>We recognize limitations in our study. Aging is associated with increasing comorbidities and worsening heart failure. As we excluded patients with substantial comorbidities, there is no guarantee that exercise training will benefit all older heart failure patients. In fact, only one patient in the older group was unable to complete the exercise training programme, compared with four patients of the middle-aged group. Nonetheless, in those able to complete the training, we have demonstrated significant improvements in neurovascular function. Another concern could be that the differing distribution of the aetiologies amongst the groups could influence the results. However, this seems unlikely, since we have recently reported that the levels of MSNA and FBF are independent of aetiology in heart failure patients.<sup><xref ref-type="bibr" rid="bibr37-1741826711414626">37</xref></sup></p>
</sec>
<sec id="sec16-1741826711414626"><title>Perspectives</title>
<p>Our study has several clinical implications. Firstly, exercise training is safe and feasible for older heart failure patients. Secondly, exercise training reduces sympathetic outflow and vasoconstriction in patients with heart failure regardless age. Thus, this non-pharmacological strategy should be recommended to older patients as well as middle-aged patients. Thirdly, MSNA and FBF are independent predictors of mortality in heart failure patients, thus the reduction in MSNA and the increase in FBF caused by exercise training may contribute to patient outcome independent of age. The significant increase in peak VO<sub>2</sub> in exercise-trained patients reinforces this idea since this parameter is a marker of functional capacity and an independent predictor of prognosis in humans with or without cardiovascular disease.<sup><xref ref-type="bibr" rid="bibr38-1741826711414626">38</xref></sup></p>
<p>In conclusion, exercise training improves centrally mediated neurovascular control in heart failure patients regardless of age. Moreover, exercise training increases functional capacity in older heart failure patients to a similar degree as in middle-aged heart failure patients.</p>
</sec>
</sec>
</body>
<back>
<sec id="sec17-1741826711414626"><title>Funding</title>
<p>This study was supported by FAPESP and, in part, by Fundaçao Zerbini. CE Negrao, MUPB Rondon, LM Antunes-Correa and TS Nobre were supported by CNPQ. HR Middlekauff was supported by NIH RO1-HL084525.</p>
</sec>
<sec id="sec18-1741826711414626"><title>Conflict of interest</title>
<p>None declared.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-1741826711414626"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AL</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><name><surname>Coats</surname><given-names>AJ</given-names></name></person-group>. <article-title>Exercise limitation in chronic heart failure: central role of the periphery</article-title>. <source>J Am Coll Cardiol</source> <year>1996</year>; <volume>28</volume>: <fpage>1092</fpage>–<lpage>1102</lpage>.</citation></ref>
<ref id="bibr2-1741826711414626"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitzman</surname><given-names>DW</given-names></name></person-group>. <article-title>Exercise intolerance</article-title>. <source>Prog Cardiovasc Dis</source> <year>2005</year>; <volume>47</volume>: <fpage>367</fpage>–<lpage>379</lpage>.</citation></ref>
<ref id="bibr3-1741826711414626"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>LW</given-names></name></person-group>. <article-title>Heart failure: who we treat versus who we study</article-title>. <source>Cardiol Clin</source> <year>2008</year>; <volume>26</volume>: <fpage>113</fpage>–<lpage>125</lpage>.</citation></ref>
<ref id="bibr4-1741826711414626"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group>. <article-title>Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease</article-title>. <source>Circulation</source> <year>2003</year>; <volume>107</volume>: <fpage>346</fpage>–<lpage>354</lpage>.</citation></ref>
<ref id="bibr5-1741826711414626"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Rich</surname><given-names>MW</given-names></name></person-group>. <article-title>Epidemiology, pathophysiology, and prognosis of heart failure in the elderly</article-title>. <source>Heart Fail Clin</source> <year>2007</year>; <volume>3</volume>: <fpage>381</fpage>–<lpage>387</lpage>.</citation></ref>
<ref id="bibr6-1741826711414626"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannel</surname><given-names>WB</given-names></name></person-group>. <article-title>Incidence and epidemiology of heart failure</article-title>. <source>Heart Fail Rev</source> <year>2000</year>; <volume>5</volume>: <fpage>167</fpage>–<lpage>173</lpage>.</citation></ref>
<ref id="bibr7-1741826711414626"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negrao</surname><given-names>CE</given-names></name><name><surname>Middlekauff</surname><given-names>HR</given-names></name></person-group>. <article-title>Adaptations in autonomic function during exercise training in heart failure</article-title>. <source>Heart Fail Rev</source> <year>2008</year>; <volume>13</volume>: <fpage>51</fpage>–<lpage>60</lpage>.</citation></ref>
<ref id="bibr8-1741826711414626"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piepoli</surname><given-names>MF</given-names></name><name><surname>Guazzi</surname><given-names>M</given-names></name><name><surname>Boriani</surname><given-names>G</given-names></name><name><surname>Cicoira</surname><given-names>M</given-names></name><name><surname>Corra</surname><given-names>U</given-names></name><name><surname>Dalla Libera</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Exercise intolerance in chronic heart failure: mechanisms and therapies</article-title>. <source><italic>Part I.</italic> Eur J Cardiovasc Prev Rehabil</source> <year>2010</year>; <volume>17</volume>: <fpage>637</fpage>–<lpage>642</lpage>.</citation></ref>
<ref id="bibr9-1741826711414626"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>AV</given-names></name><name><surname>Callister</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>DG</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group>. <article-title>Age and gender influence muscle sympathetic nerve activity at rest in healthy humans</article-title>. <source>Hypertension</source> <year>1993</year>; <volume>21</volume>: <fpage>498</fpage>–<lpage>503</lpage>.</citation></ref>
<ref id="bibr10-1741826711414626"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narkiewicz</surname><given-names>K</given-names></name><name><surname>Phillips</surname><given-names>BG</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Hering</surname><given-names>D</given-names></name><name><surname>Bieniaszewski</surname><given-names>L</given-names></name><name><surname>Somers</surname><given-names>VK</given-names></name></person-group>. <article-title>Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity</article-title>. <source>Hypertension</source> <year>2005</year>; <volume>45</volume>: <fpage>522</fpage>–<lpage>525</lpage>.</citation></ref>
<ref id="bibr11-1741826711414626"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Mello Franco</surname><given-names>FG</given-names></name><name><surname>Santos</surname><given-names>AC</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Trombetta</surname><given-names>IC</given-names></name><name><surname>Strunz</surname><given-names>C</given-names></name><name><surname>Braga</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Effects of home-based exercise training on neurovascular control in patients with heart failure</article-title>. <source>Eur J Heart Fail</source> <year>2006</year>; <volume>8</volume>: <fpage>851</fpage>–<lpage>855</lpage>.</citation></ref>
<ref id="bibr12-1741826711414626"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>PM</given-names></name><name><surname>Cockburn</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>PJ</given-names></name><name><surname>Webster</surname><given-names>JK</given-names></name><name><surname>Betihavas</surname><given-names>V</given-names></name><name><surname>Howes</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2010</year>; <volume>17</volume>: <fpage>393</fpage>–<lpage>402</lpage>.</citation></ref>
<ref id="bibr13-1741826711414626"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antunes-Correa</surname><given-names>LM</given-names></name><name><surname>Melo</surname><given-names>RC</given-names></name><name><surname>Nobre</surname><given-names>TS</given-names></name><name><surname>Ueno</surname><given-names>LM</given-names></name><name><surname>Franco</surname><given-names>FG</given-names></name><name><surname>Braga</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure</article-title>. <source>Eur J Heart Fail</source> <year>2010</year>; <volume>12</volume>: <fpage>58</fpage>–<lpage>65</lpage>.</citation></ref>
<ref id="bibr14-1741826711414626"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roveda</surname><given-names>F</given-names></name><name><surname>Middlekauff</surname><given-names>HR</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Reis</surname><given-names>SF</given-names></name><name><surname>Souza</surname><given-names>M</given-names></name><name><surname>Nastari</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial</article-title>. <source>J Am Coll Cardiol</source> <year>2003</year>; <volume>42</volume>: <fpage>854</fpage>–<lpage>860</lpage>.</citation></ref>
<ref id="bibr15-1741826711414626"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraga</surname><given-names>R</given-names></name><name><surname>Franco</surname><given-names>FG</given-names></name><name><surname>Roveda</surname><given-names>F</given-names></name><name><surname>de Matos</surname><given-names>LN</given-names></name><name><surname>Braga</surname><given-names>AM</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><etal/></person-group>. <article-title>Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol</article-title>. <source>Eur J Heart Fail</source> <year>2007</year>; <volume>9</volume>: <fpage>630</fpage>–<lpage>636</lpage>.</citation></ref>
<ref id="bibr16-1741826711414626"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coats</surname><given-names>AJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Radaelli</surname><given-names>A</given-names></name><name><surname>McCance</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>TE</given-names></name><name><surname>Bernardi</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Controlled trial of physical training in chronic heart failure</article-title>. <source><italic>Exercise performance, hemodynamics, ventilation, and autonomic function</italic>. Circulation</source> <year>1992</year>; <volume>85</volume>: <fpage>2119</fpage>–<lpage>2131</lpage>.</citation></ref>
<ref id="bibr17-1741826711414626"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiilavuori</surname><given-names>K</given-names></name><name><surname>Toivonen</surname><given-names>L</given-names></name><name><surname>Naveri</surname><given-names>H</given-names></name><name><surname>Leinonen</surname><given-names>H</given-names></name></person-group>. <article-title>Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability</article-title>. <source>Eur Heart J</source> <year>1995</year>; <volume>16</volume>: <fpage>490</fpage>–<lpage>495</lpage>.</citation></ref>
<ref id="bibr18-1741826711414626"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keteyian</surname><given-names>SJ</given-names></name><name><surname>Levine</surname><given-names>AB</given-names></name><name><surname>Brawner</surname><given-names>CA</given-names></name><name><surname>Kataoka</surname><given-names>T</given-names></name><name><surname>Rogers</surname><given-names>FJ</given-names></name><name><surname>Schairer</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Exercise training in patients with heart failure</article-title>. <source><italic>A randomized, controlled trial</italic>. Ann Intern Med</source> <year>1996</year>; <volume>124</volume>: <fpage>1051</fpage>–<lpage>1057</lpage>.</citation></ref>
<ref id="bibr19-1741826711414626"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyni-Lenne</surname><given-names>R</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name><name><surname>Europe</surname><given-names>E</given-names></name><name><surname>Jansson</surname><given-names>E</given-names></name><name><surname>Sylven</surname><given-names>C</given-names></name></person-group>. <article-title>Exercise-based rehabilitation improves skeletal muscle capacity, exercise tolerance, and quality of life in both women and men with chronic heart failure</article-title>. <source>J Card Fail</source> <year>1998</year>; <volume>4</volume>: <fpage>9</fpage>–<lpage>17</lpage>.</citation></ref>
<ref id="bibr20-1741826711414626"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negrao</surname><given-names>CE</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Tinucci</surname><given-names>T</given-names></name><name><surname>Alves</surname><given-names>MJ</given-names></name><name><surname>Roveda</surname><given-names>F</given-names></name><name><surname>Braga</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Abnormal neurovascular control during exercise is linked to heart failure severity</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <year>2001</year>; <volume>280</volume>: <fpage>H1286</fpage>–<lpage>H1292</lpage>.</citation></ref>
<ref id="bibr21-1741826711414626"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delius</surname><given-names>W</given-names></name><name><surname>Hagbarth</surname><given-names>KE</given-names></name><name><surname>Hongell</surname><given-names>A</given-names></name><name><surname>Wallin</surname><given-names>BG</given-names></name></person-group>. <article-title>Manoeuvres affecting sympathetic outflow in human muscle nerves</article-title>. <source>Acta Physiol Scand</source> <year>1972</year>; <volume>84</volume>: <fpage>82</fpage>–<lpage>94</lpage>.</citation></ref>
<ref id="bibr22-1741826711414626"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vallbo</surname><given-names>AB</given-names></name><name><surname>Hagbarth</surname><given-names>KE</given-names></name><name><surname>Torebjork</surname><given-names>HE</given-names></name><name><surname>Wallin</surname><given-names>BG</given-names></name></person-group>. <article-title>Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves</article-title>. <source>Physiol Rev</source> <year>1979</year>; <volume>59</volume>: <fpage>919</fpage>–<lpage>957</lpage>.</citation></ref>
<ref id="bibr23-1741826711414626"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>LM</given-names></name><name><surname>Drager</surname><given-names>LF</given-names></name><name><surname>Rodrigues</surname><given-names>AC</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Braga</surname><given-names>AM</given-names></name><name><surname>Mathias</surname><given-names>W</given-names><suffix>Jr</suffix></name><etal/></person-group>. <article-title>Effects of exercise training in patients with chronic heart failure and sleep apnea</article-title>. <source>Sleep</source> <year>2009</year>; <volume>32</volume>: <fpage>637</fpage>–<lpage>647</lpage>.</citation></ref>
<ref id="bibr24-1741826711414626"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schiller</surname><given-names>NB</given-names></name><name><surname>Shah</surname><given-names>PM</given-names></name><name><surname>Crawford</surname><given-names>M</given-names></name><name><surname>DeMaria</surname><given-names>A</given-names></name><name><surname>Devereux</surname><given-names>R</given-names></name><name><surname>Feigenbaum</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms</article-title>. <source>J Am Soc Echocardiogr</source> <year>1989</year>; <volume>2</volume>: <fpage>358</fpage>–<lpage>367</lpage>.</citation></ref>
<ref id="bibr25-1741826711414626"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenwood</surname><given-names>JP</given-names></name><name><surname>Scott</surname><given-names>EM</given-names></name><name><surname>Stoker</surname><given-names>JB</given-names></name><name><surname>Mary</surname><given-names>DA</given-names></name></person-group>. <article-title>Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive</article-title>. <source>J Am Coll Cardiol</source> <year>2001</year>; <volume>38</volume>: <fpage>1711</fpage>–<lpage>1717</lpage>.</citation></ref>
<ref id="bibr26-1741826711414626"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rondon</surname><given-names>E</given-names></name><name><surname>Brasileiro-Santos</surname><given-names>MS</given-names></name><name><surname>Moreira</surname><given-names>ED</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Mattos</surname><given-names>KC</given-names></name><name><surname>Coelho</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <year>2006</year>; <volume>291</volume>: <fpage>H2801</fpage>–<lpage>H286</lpage>.</citation></ref>
<ref id="bibr27-1741826711414626"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JL</given-names></name><name><surname>Kulakofsky</surname><given-names>J</given-names></name><name><surname>Zucker</surname><given-names>IH</given-names></name></person-group>. <article-title>Exercise training enhances baroreflex control of heart rate by a vagal mechanism in rabbits with heart failure</article-title>. <source>J Appl Physiol</source> <year>2002</year>; <volume>92</volume>: <fpage>2403</fpage>–<lpage>2408</lpage>.</citation></ref>
<ref id="bibr28-1741826711414626"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YL</given-names></name><name><surname>Sun</surname><given-names>SY</given-names></name><name><surname>Overholt</surname><given-names>JL</given-names></name><name><surname>Prabhakar</surname><given-names>NR</given-names></name><name><surname>Rozanski</surname><given-names>GJ</given-names></name><name><surname>Zucker</surname><given-names>IH</given-names></name><etal/></person-group>. <article-title>Attenuated outward potassium currents in carotid body glomus cells of heart failure rabbit: involvement of nitric oxide</article-title>. <source>J Physiol</source> <year>2004</year>; <volume>555</volume>: <fpage>219</fpage>–<lpage>229</lpage>.</citation></ref>
<ref id="bibr29-1741826711414626"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Jones</surname><given-names>PP</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group>. <article-title>Limb blood flow and vascular conductance are reduced with age in healthy humans: relation to elevations in sympathetic nerve activity and declines in oxygen demand</article-title>. <source>Circulation</source> <year>1999</year>; <volume>100</volume>: <fpage>164</fpage>–<lpage>170</lpage>.</citation></ref>
<ref id="bibr30-1741826711414626"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name></person-group>. <article-title>Age-related decreases in basal limb blood flow in humans: time course, determinants and habitual exercise effects</article-title>. <source>J Physiol</source> <year>2001</year>; <volume>531</volume>: <fpage>573</fpage>–<lpage>579</lpage>.</citation></ref>
<ref id="bibr31-1741826711414626"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name></person-group>. <article-title>Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a ‘set up' for vascular disease</article-title>. <source>Circulation</source> <year>2003</year>; <volume>107</volume>: <fpage>139</fpage>–<lpage>146</lpage>.</citation></ref>
<ref id="bibr32-1741826711414626"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taddei</surname><given-names>S</given-names></name><name><surname>Virdis</surname><given-names>A</given-names></name><name><surname>Ghiadoni</surname><given-names>L</given-names></name><name><surname>Salvetti</surname><given-names>G</given-names></name><name><surname>Bernini</surname><given-names>G</given-names></name><name><surname>Magagna</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Age-related reduction of NO availability and oxidative stress in humans</article-title>. <source>Hypertension</source> <year>2001</year>; <volume>38</volume>: <fpage>274</fpage>–<lpage>279</lpage>.</citation></ref>
<ref id="bibr33-1741826711414626"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seals</surname><given-names>DR</given-names></name><name><surname>Dinenno</surname><given-names>FA</given-names></name></person-group>. <article-title>Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <year>2004</year>; <volume>287</volume>: <fpage>H1895</fpage>–<lpage>H1905</lpage>.</citation></ref>
<ref id="bibr34-1741826711414626"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Fiehn</surname><given-names>E</given-names></name><name><surname>Weigl</surname><given-names>C</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><name><surname>Hamann</surname><given-names>C</given-names></name><name><surname>Kaiser</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure</article-title>. <source>Circulation</source> <year>1998</year>; <volume>98</volume>: <fpage>2709</fpage>–<lpage>2715</lpage>.</citation></ref>
<ref id="bibr35-1741826711414626"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeSouza</surname><given-names>CA</given-names></name><name><surname>Shapiro</surname><given-names>LF</given-names></name><name><surname>Clevenger</surname><given-names>CM</given-names></name><name><surname>Dinenno</surname><given-names>FA</given-names></name><name><surname>Monahan</surname><given-names>KD</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men</article-title>. <source>Circulation</source> <year>2000</year>; <volume>102</volume>: <fpage>1351</fpage>–<lpage>1357</lpage>.</citation></ref>
<ref id="bibr36-1741826711414626"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parnell</surname><given-names>MM</given-names></name><name><surname>Holst</surname><given-names>DP</given-names></name><name><surname>Kaye</surname><given-names>DM</given-names></name></person-group>. <article-title>Augmentation of endothelial function following exercise training is associated with increased L-arginine transport in human heart failure</article-title>. <source>Clin Sci (Lond)</source> <year>2005</year>; <volume>109</volume>: <fpage>523</fpage>–<lpage>530</lpage>.</citation></ref>
<ref id="bibr37-1741826711414626"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negrao</surname><given-names>CE</given-names></name><name><surname>Santos</surname><given-names>AC</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Franco</surname><given-names>FG</given-names></name><name><surname>Ianni</surname><given-names>B</given-names></name><name><surname>Rochitte</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Muscle sympathetic nerve activity in patients with Chagas' disease</article-title>. <source>Int J Cardiol</source> <year>2009</year>; <volume>137</volume>: <fpage>252</fpage>–<lpage>259</lpage>.</citation></ref>
<ref id="bibr38-1741826711414626"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Prakash</surname><given-names>M</given-names></name><name><surname>Froelicher</surname><given-names>V</given-names></name><name><surname>Do</surname><given-names>D</given-names></name><name><surname>Partington</surname><given-names>S</given-names></name><name><surname>Atwood</surname><given-names>JE</given-names></name></person-group>. <article-title>Exercise capacity and mortality among men referred for exercise testing</article-title>. <source>N Engl J Med</source> <year>2002</year>; <volume>346</volume>: <fpage>793</fpage>–<lpage>801</lpage>.</citation></ref>
</ref-list>
</back>
</article>